
TY  - JOUR
TI  - ASBMR 30th Annual Meeting 1001–1300
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 23
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650231302
DO  - doi:10.1002/jbmr.5650231302
SP  - S2
EP  - S85
PY  - 2008
ER  - 

TY  - JOUR
TI  - ADF Abstracts 2014
JO  - Experimental Dermatology
JA  - Exp Dermatol
VL  - 23
IS  - 3
SN  - 0906-6705
UR  - https://doi.org/10.1111/exd.12314
DO  - doi:10.1111/exd.12314
SP  - e1
EP  - e60
PY  - 2014
ER  - 

TY  - JOUR
TI  - Print Only
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 28
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.12363_3
DO  - doi:10.1111/jgh.12363_3
SP  - 694
EP  - 919
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster Sessions (PS)
JO  - European Journal of Biochemistry
VL  - 270
IS  - s1
SN  - 0014-2956
UR  - https://doi.org/10.1046/j.1432-1033.270.s1.8.x
DO  - doi:10.1046/j.1432-1033.270.s1.8.x
SP  - 32
EP  - 235
PY  - 2003
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Epilepsia
JA  - Epilepsia
VL  - 56
IS  - S1
SN  - 0013-9580
UR  - https://doi.org/10.1111/epi.13241
DO  - doi:10.1111/epi.13241
SP  - 3
EP  - 263
PY  - 2015
ER  - 

TY  - JOUR
TI  - Published Only
JO  - Journal of Digestive Diseases
JA  - Journal of Digestive Diseases
VL  - 16
IS  - S1
SN  - 1751-2972
UR  - https://doi.org/10.1111/1751-2980.12277
DO  - doi:10.1111/1751-2980.12277
SP  - 29
EP  - 146
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Epilepsia
JA  - Epilepsia
VL  - 58
IS  - S5
SN  - 0013-9580
UR  - https://doi.org/10.1111/epi.13944
DO  - doi:10.1111/epi.13944
SP  - S5
EP  - S199
PY  - 2017
ER  - 

TY  - JOUR
AU  - Sutherland, Heidi G.
AU  - Griffiths, Lyn R.
TI  - Genetics of Migraine: Insights into the Molecular Basis of Migraine Disorders
JO  - Headache: The Journal of Head and Face Pain
JA  - Headache: The Journal of Head and Face Pain
VL  - 57
IS  - 4
SN  - 0017-8748
UR  - https://doi.org/10.1111/head.13053
DO  - doi:10.1111/head.13053
SP  - 537
EP  - 569
KW  - migraine
KW  - genetics
KW  - hemiplegic migraine
KW  - genome-wide association study
PY  - 2017
AB  - Migraine is a complex, debilitating neurovascular disorder, typically characterized by recurring, incapacitating attacks of severe headache often accompanied by nausea and neurological disturbances. It has a strong genetic basis demonstrated by rare migraine disorders caused by mutations in single genes (monogenic), as well as familial clustering of common migraine which is associated with polymorphisms in many genes (polygenic). Hemiplegic migraine is a dominantly inherited, severe form of migraine with associated motor weakness. Family studies have found that mutations in three different ion channels genes, CACNA1A, ATP1A2, and SCN1A can be causal. Functional studies of these mutations has shown that they can result in defective regulation of glutamatergic neurotransmission and the excitatory/inhibitory balance in the brain, which lowers the threshold for cortical spreading depression, a wave of cortical depolarization thought to be involved in headache initiation mechanisms. Other putative genes for monogenic migraine include KCKN18, PRRT2, and CSNK1D, which can also be involved with other disorders. There are a number of primarily vascular disorders caused by mutations in single genes, which are often accompanied by migraine symptoms. Mutations in NOTCH3 causes cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a hereditary cerebrovascular disease that leads to ischemic strokes and dementia, but in which migraine is often present, sometimes long before the onset of other symptoms. Mutations in the TREX1 and COL4A1 also cause vascular disorders, but often feature migraine. With respect to common polygenic migraine, genome-wide association studies have now identified single nucleotide polymorphisms at 38 loci significantly associated with migraine risk. Functions assigned to the genes in proximity to these loci suggest that both neuronal and vascular pathways also contribute to the pathophysiology of common migraine. Further studies are required to fully understand these findings and translate them into treatment options for migraine patients.
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Immunology
VL  - 137
IS  - s1
SN  - 0019-2805
UR  - https://doi.org/10.1111/imm.12002
DO  - doi:10.1111/imm.12002
SP  - 185
EP  - 772
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Alcoholism: Clinical and Experimental Research
VL  - 36
IS  - s2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2012.01917.x
DO  - doi:10.1111/j.1530-0277.2012.01917.x
SP  - 1A
EP  - 152A
PY  - 2012
ER  - 

TY  - JOUR
TI  - SARS abstracts
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 102
IS  - s5
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.9822
DO  - doi:10.1002/bjs.9822
SP  - 3
EP  - 52
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts List
JO  - Journal of Tissue Engineering and Regenerative Medicine
JA  - J Tissue Eng Regen Med
VL  - 7
IS  - s1
SN  - 1932-6254
UR  - https://doi.org/10.1002/term.1822
DO  - doi:10.1002/term.1822
SP  - 6
EP  - 52
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - The FEBS Journal
VL  - 275
IS  - s1
SN  - 1742-464X
UR  - https://doi.org/10.1111/j.1742-4658.2008.06448.x
DO  - doi:10.1111/j.1742-4658.2008.06448.x
SP  - 99
EP  - 437
PY  - 2008
ER  - 

TY  - JOUR
TI  - WORLD TRANSPLANT CONGRESS 2006 POSTER ABSTRACTS
JO  - American Journal of Transplantation
VL  - 6
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2006.01447.x
DO  - doi:10.1111/j.1600-6143.2006.01447.x
SP  - 473
EP  - 1061
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Movement Disorders
JA  - Mov Disord.
VL  - 34
IS  - S2
SN  - 0885-3185
UR  - https://doi.org/10.1002/mds.27795
DO  - doi:10.1002/mds.27795
SP  - S1
EP  - S930
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - The FEBS Journal
JA  - FEBS J
VL  - 281
IS  - s1
SN  - 1742-464X
UR  - https://doi.org/10.1111/febs.12919
DO  - doi:10.1111/febs.12919
SP  - 65
EP  - 784
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 43
IS  - S31
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.20939
DO  - doi:10.1002/ppul.20939
SP  - 202
EP  - 462
PY  - 2008
ER  - 

TY  - JOUR
AU  - Chen, Ying-Ju
AU  - Chan, Ding-Cheng
AU  - Chiang, Chih-Kang
AU  - Wang, Ching-Chia
AU  - Yang, Ting-Hua
AU  - Lan, Kuo-Cheng
AU  - Chao, Sung-Chuan
AU  - Tsai, Keh-Sung
AU  - Yang, Rong-Sen
AU  - Liu, Shing-Hwa
TI  - Advanced glycation end-products induced VEGF production and inflammatory responses in human synoviocytes via RAGE-NF-κB pathway activation
JO  - Journal of Orthopaedic Research
JA  - J. Orthop. Res. 
VL  - 34
IS  - 5
SN  - 0736-0266
UR  - https://doi.org/10.1002/jor.23083
DO  - doi:10.1002/jor.23083
SP  - 791
EP  - 800
KW  - osteoarthritis
KW  - advanced glycation end products (AGEs)
KW  - synoviocytes
KW  - vascular endothelial growth factor
KW  - receptor for AGEs (RAGE)
PY  - 2016
AB  - ABSTRACT Aging and diabetes are known to be the major cause to affect the progression of osteoarthritis (OA). Advanced glycation end products (AGEs) have been observed to accumulate in various organs especially in joint tissue and do damage to the joint tissue during aging and diabetes. Synovial angiogenesis and inflammation are observed across the full range of OA severity. The signaling pathway of AGEs on vascular endothelial growth factor (VEGF) production and inflammatory responses in synoviocytes are still unclear. Here, we investigated the role of receptor for AGEs (RAGE) and the signaling pathway involved in AGEs-induced VEGF production and inflammatory responses in human synoviocytes. Human synoviocytes were cultured and treated with AGEs (25?100?µg/ml). AGEs significantly induced the protein expressions of cyclooxygenase-2 (COX-2) and VEGF and the productions of prostaglandin-E2 (PGE2), VEGF, interleukin-6 (IL-6), and metalloproteinase-13 (MMP-13) in human synoviocytes in a dose-dependent manner. Moreover, AGEs markedly activated the phosphorylations of I?B kinase (IKK)α/?, I?Bα, and nuclear factor (NF)-?B-p65 proteins in human synoviocytes in a time-dependent manner. Treatment with neutralizing antibody for RAGE statistically significantly decreased the AGEs-induced increase in COX-2, VEGF, PGE2, IL-6, and MMP13 and AGEs-activated NF-?B pathway activation. Taken together, these findings indicate that AGEs are capable of inducing VEGF production and inflammatory responses via RAGE-NF-?B pathway activation in human synoviocytes. ? 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:791?800, 2016.
ER  - 

TY  - JOUR
TI  - Poster Sessions Monday/Tuesday
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 150
IS  - S1
SN  - 0022-3042
UR  - https://doi.org/10.1111/jnc.14776
DO  - doi:10.1111/jnc.14776
SP  - 73
EP  - 161
PY  - 2019
ER  - 

TY  - JOUR
AU  - Jiang, Yi-Bin
AU  - Wei, Kai-Yan
AU  - Zhang, Xu-Yang
AU  - Feng, Hua
AU  - Hu, Rong
TI  - White matter repair and treatment strategy after intracerebral hemorrhage
JO  - CNS Neuroscience & Therapeutics
JA  - CNS Neurosci Ther
VL  - 25
IS  - 10
SN  - 1755-5930
UR  - https://doi.org/10.1111/cns.13226
DO  - doi:10.1111/cns.13226
SP  - 1113
EP  - 1125
KW  - hemorrhage
KW  - regeneration
KW  - repair
KW  - white matter injury
PY  - 2019
AB  - Abstract The predilection site of intracerebral hemorrhage (ICH) is in the basal ganglia, which is rich in white matter (WM) fiber bundles, such as cerebrospinal tract in the internal capsule. ICH induced damage to this area can easily lead to severe neurological dysfunction and affects the prognosis and quality of life of patients. At present, the pathophysiological mechanisms of white matter injury (WMI) after ICH have attracted researchers' attention, but studies on the repair and recovery mechanisms and therapy strategies remain rare. In this review, we mainly summarized the WM recovery and treatment strategies after ICH by updating the WMI-related content by reviewing the latest researches and proposing the bottleneck of the current research.
ER  - 
